Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in IVVD — Invivyd, Inc.

CIK 886982 NEW YORK, NY
Back to IVVD Full portfolio

Position in IVVD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$853,296
-$2,541,582 QoQ
Shares Held
978,552
-62.5% QoQ
Ownership
0.332%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 124 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IVVD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. IVVD ranks #263 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in IVVD

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $853,296 978,552
2026-03-31 $3,394,878 2,611,445
2025-12-31 $5,369,154 2,173,747
2025-09-30 $47,214 42,922
2025-06-30 $277,322 387,864
2025-03-31 $154,861 255,970
2024-12-31 $110,817 250,153
2024-09-30 $168,684 165,377
2024-06-30 $166,436 151,306
2024-03-31 $2,676,907 602,907
2023-12-31 $213,299 54,137
2023-09-30 $39,016 22,951
2023-06-30 $45,950 43,762
2023-03-31 $98,780 82,317
2022-12-31 $97,022 64,682
2022-09-30 $439,651 140,464
2022-06-30 $1,353,209 412,564
2022-03-31 $174,752 38,323
2021-12-31 $166,856 22,983